Peptide Synthesis Market

Peptide Synthesis Market by Product (Equipment and Reagents & Consumables), Peptide Types (Synthetic Peptides, Custom Peptides, Cosmetic Peptides, and Others), Application (Therapeutics, Diagnostics, Research, and Cosmetics), End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), and Cosmetic Companies), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of chronic diseases, growing applications in diagnostics and imaging, expanding applications in cosmetics, and growing product development activities across the globe.

The peptide synthesis market is estimated to grow at a CAGR of 10.13% during the forecast period from 2025 to 2032. The peptide synthesis market is experiencing significant growth due to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which drive demand for peptide-based therapeutics known for their high specificity and efficacy. Peptides are also gaining prominence in diagnostics and imaging, where their ability to act as molecular probes enhances the precision of disease detection. Expanding applications in cosmetics, especially in anti-aging and skin rejuvenation products, further contribute to market expansion. Additionally, growing product development activities globally, fueled by advancements in synthesis technologies and rising investments in R&D, are enabling the creation of innovative peptide-based solutions across various industries, collectively these factors are expected to boost the overall market of peptide synthesis market during the forecast period from 2025 to 2032.

Peptide Synthesis Market Dynamics:

According to the International Agency for Research on Cancer (2024), an estimated 20 million new cancer cases were reported globally in 2022, with projections indicating an increase to 32.6 million by 2045. Similarly, the World Health Organization (2024) reported that the number of people living with diabetes rose from 200 million in 1990 to 830 million in 2022. This rising prevalence of cancer and diabetes is fueling the peptide synthesis market, as peptides offer targeted and efficient therapeutic solutions. In oncology, peptides are utilized in vaccines, tumor-targeting agents, and immunotherapies due to their specificity and reduced side effects. For diabetes management, essential peptides such as insulin and GLP-1 receptor agonists help regulate blood sugar levels and address related complications, including weight management and cardiovascular risks, meeting the increasing demand for advanced treatments.  

The global approval of peptide-based drugs for managing diabetes, cancer, and other chronic conditions highlights their therapeutic significance, further driving innovation and production within the peptide synthesis market. For example, in January 2024, Glenmark Pharmaceuticals Ltd. launched Lirafit™, a biosimilar of the widely used anti-diabetic drug Liraglutide, in India. Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), enhances glucose-dependent insulin secretion while reducing inappropriate glucagon release. It has received global approval for the treatment of type 2 diabetes mellitus in adults.  

Beyond pharmaceuticals, peptides are gaining traction in the cosmetic industry due to their ability to stimulate collagen production, improve skin elasticity, and reduce fine lines and wrinkles. Growing consumer awareness of these anti-aging benefits has driven demand for peptide-infused skincare products. Specific peptides, such as Dipeptide-2 and Acetyl Tetrapeptide-5, are increasingly used in eye creams to reduce puffiness and dark circles by enhancing lymphatic drainage. These compounds also contribute to improved skin hydration, firmness, and texture, further expanding their applications in cosmetic formulations.  

The expanding use of peptides in both medical and cosmetic fields is propelling the peptide synthesis market, prompting manufacturers to invest heavily in research and development. The surge in demand for personalized and targeted skincare solutions, combined with a broader consumer shift toward innovative therapies, has accelerated the market's growth. This trend is expected to persist, driving the global peptide synthesis market from 2025 to 2032.  

However, certain challenges may slightly hinder market growth. Peptide synthesis, particularly for long and complex sequences, requires advanced technologies, specialized reagents, and substantial resources, making the process costly. Additionally, stringent regulatory requirements, especially concerning clinical trials and drug approvals, can pose obstacles to market expansion.  

Peptide Synthesis Market Segment Analysis:

Peptide Synthesis Market by Product (Equipment and Reagents & Consumables), Peptide Types (Synthetic Peptides, Custom Peptides, Cosmetic Peptides, and Others), Application (Therapeutics, Diagnostics, Research, and Cosmetics), End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), and Cosmetic Companies), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)   

In the product segment of the peptide synthesis market, the equipment category is expected to hold a significant share in 2024. Technological advancements in equipment play a crucial role in driving market growth by streamlining processes, enhancing efficiency, and improving the quality of synthesized peptides. Automated peptide synthesizers, in particular, have revolutionized the field by enabling high-precision and reproducible peptide production. These systems facilitate efficient solid-phase peptide synthesis (SPPS), reducing manual labor, minimizing errors, and saving both time and costs.  

Automated peptide synthesizers support high-throughput synthesis, allowing for the rapid production of multiple peptides simultaneously a critical capability for pharmaceutical research, drug discovery, and industrial applications. Their ability to handle complex and long peptide sequences has expanded the development of peptide-based therapeutics, fostering innovations in areas such as cancer treatment, metabolic disorders, and vaccine development.  

Furthermore, modern peptide synthesizers are equipped with advanced features like real-time monitoring, optimized reaction protocols, and the ability to accommodate diverse chemistries. These capabilities not only enhance production efficiency but also make the process more cost-effective and environmentally friendly. The increasing demand for custom, high-purity peptides in research, diagnostics, and therapeutics further drives the adoption of these advanced systems.  

As industries embrace automated synthesizers to meet the growing global demand for peptide-based products, they contribute significantly to market expansion. These machines enable large-scale, high-quality peptide production, supporting advancements in healthcare, biotechnology, and cosmetics. For instance, in June 2024, Vapourtec Ltd. launched the Peptide-ExplorerLT, a compact and flexible peptide synthesizer. This device produces high-quality peptides, features a smaller footprint, and is offered at a more accessible price point, catering to both academic and commercial users.  

Thus, the factors mentioned above are expected to boost the equipment segment, thereby driving the overall growth of the global peptide synthesis market.  

North America is expected to dominate the overall peptide synthesis market:

North America is projected to account for the largest share of the peptide synthesis market in 2024. This dominance is attributed to several factors, including a well-established pharmaceutical and biotechnology industry, substantial investments in research and development (R&D), and a strong emphasis on innovative drug discovery. The region benefits from the presence of major industry players offering advanced peptide synthesis technologies to meet the growing demand for therapeutic peptides, particularly in treating chronic conditions such as cancer and diabetes. Additionally, North America's favorable regulatory environment, increasing adoption of personalized medicine, and robust collaborations between academia and industry further contribute to the market’s growth. The rising focus on cosmetic peptides and the availability of sophisticated infrastructure also reinforce North America’s leadership in this segment.  

According to the International Agency for Research on Cancer (2024), the estimated number of new cancer cases in North America was 2.67 million in 2022, with projections indicating an increase to 3.83 million by 2045. Similarly, data from the American Diabetes Association (2023) revealed that, in 2021, approximately 38.4 million individuals in the United States representing 11.6% of the population were living with diabetes. Of these, 2 million had type 1 diabetes, including roughly 304,000 children and adolescents. Among the adult population, 29.7 million cases were diagnosed, while 8.7 million remained undiagnosed. These figures underscore the high prevalence of diabetes in the region and the urgent need for early detection, effective management, and innovative treatment strategies.  

Peptides play a pivotal role in managing both cancer and diabetes, fueling their demand in therapeutic applications. In oncology, tumor-targeting peptides, cancer vaccines, and oncolytic peptides are preferred for their high specificity and reduced side effects compared to conventional treatments like chemotherapy. For diabetes, peptides such as insulin and GLP-1 receptor agonists are essential, particularly in addressing the rising incidence of type 2 diabetes. These peptide-based therapies not only help regulate blood glucose levels but also mitigate related complications, driving the growth of the peptide synthesis market.  

Moreover, strategic initiatives by key market players are further bolstering the peptide synthesis market across North America. These activities include expanding product portfolios, increasing investments in technological advancements and infrastructure, and forming strategic partnerships to enhance operational efficiency. For instance, in September 2024, Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the launch of its new liquid-phase peptide synthesis (LPPS) technology. Unlike traditional methods that rely on specialized solid-phase reactors, the LPPS technology uses standard active pharmaceutical ingredient (API) batch reactors and continuous flow systems. This innovation significantly reduces solvent consumption and minimizes the need for excess reagents compared to conventional solid-phase peptide synthesis, making the process more sustainable and cost-effective.  

In conclusion, the combination of robust healthcare infrastructure, high disease prevalence, advanced technology adoption, and proactive industry strategies is expected to drive substantial growth in the North American peptide synthesis market during the forecast period.  

Peptide Synthesis Market Key Players:

Some of the key market players operating in the peptide synthesis market include Thermo Fisher Scientific, Merck KGaA, Biosynth, Cambrex Corporation, Asymchem Inc., Vapourtec Ltd., CSBio, Activotec., Biotage, CEM Corporation, AltaBioscience Ltd., Spectrum Chemical, Highfine Biotech Co., Ltd., Bachem Holding AG, Ambio, Inc.,  and others.

Recent Developmental Activities in the Peptide Synthesis Market:

• In August 2024, Kenvue Inc. launched Neutrogena® Collagen Bank™ featuring its patented micro-peptide technology. The product aimed to address the needs of Gen Z consumers seeking proactive anti-aging solutions. The Collagen Bank™ used a micro-peptide technology, two times smaller than traditional anti-aging peptides, allowing it to penetrate deeper into the skin, targeting five critical markers for skin firmness: elastin, pro-collagen, hyaluronic acid, fibronectin, and decorin.
• In April 2022, CEM Corporation announced the release of its Liberty 2.0 instrumentation line, the next generation of automated microwave peptide synthesizers.

Key Takeaways From the Peptide Synthesis Market Report Study

• Market size analysis for current peptide synthesis size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the peptide synthesis market.
• Various opportunities available for the other competitors in the peptide synthesis market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current peptide synthesis market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for peptide synthesis market growth in the coming future?

Target Audience Who Can be Benefited From This Peptide Synthesis Market Report Study

• Peptide synthesis product providers
• Research organizations and consulting companies 
• Peptide synthesis -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in peptide synthesis 
• Various end-users who want to know more about the peptide synthesis market and the latest technological developments in the peptide synthesis market.  

Frequently Asked Questions for the Peptide Synthesis Market:

1. What is peptide synthesis?

• Peptide synthesis is the process of creating peptides, which are short chains of amino acids, by chemically linking individual amino acids in a specific sequence. This can be done through solid-phase peptide synthesis (SPPS), where peptides are built step-by-step on a solid support, or through liquid-phase synthesis for smaller peptides. 

2. What is the market for peptide synthesis?

• The peptide synthesis market is estimated to grow at a CAGR of 10.13% during the forecast period from 2025 to 2032. 

3. What are the drivers for the global peptide synthesis market?

• The peptide synthesis market is experiencing significant growth due to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, which is driving demand for peptide-based therapeutics known for their high specificity and efficacy. Peptides are also gaining prominence in diagnostics and imaging, where their ability to act as molecular probes enhances the precision of disease detection. Expanding applications in cosmetics, especially in anti-aging and skin rejuvenation products, further contribute to market expansion. Collectively these factors are expected to boost the overall market of peptide synthesis market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global peptide synthesis market?

• Some of the key market players operating in peptide synthesis are Thermo Fisher Scientific, Merck KGaA, Biosynth, Cambrex Corporation, Asymchem Inc., Vapourtec Ltd., CSBio, Activotec., Biotage, CEM Corporation, AltaBioscience Ltd., Spectrum Chemical, Highfine Biotech Co., Ltd., Bachem Holding AG, Ambio, Inc., and others.

5. Which region has the highest share in the global peptide synthesis market?

• North America is projected to account for the largest share of the peptide synthesis market in 2024. This dominance is attributed to several factors, including a well-established pharmaceutical and biotechnology industry, substantial investments in research and development (R&D), and a strong emphasis on innovative drug discovery. The region benefits from the presence of major industry players offering advanced peptide synthesis technologies to meet the growing demand for therapeutic peptides, particularly in treating chronic conditions such as cancer and diabetes.